---
document_datetime: 2024-10-31 10:35:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ibuprofen-genorph-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: ibuprofen-genorph-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 0.9736738
conversion_datetime: 2025-12-30 09:07:22.180847
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Ibuprofen Gen.Orph

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0002               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 30/10/2024                          |                                             | Labelling and PL                 |           |

<!-- image -->

<!-- image -->